fdaconsultingusa.com

What it is

FDA Consulting LLC (fdaconsultingusa.com) is an FDA regulatory and compliance consulting firm serving companies in medical devices, pharmaceuticals, biologics, diagnostics, and combination products. Its core offering is not SaaS software, but support for FDA 510(k) submissions, registration, compliance remediation, clinical trials, and certain manufacturing engineering needs.

Core capabilities

Based on the site content, its services cover regulatory pathways such as medical device 510(k) submissions, Pre-Sub/Q-Sub, IDE, PMA, De Novo, 513(g), and MAF. It also provides support for product classification assessments, gap analyses, regulatory strategy, test documentation collection, labeling and claims compliance, UDI/GUDID, FDA registration, and U.S. agent services. On the quality and compliance side, it covers ISO 13485, FDA QSR, cGMP, ISO 14971 risk management, as well as consulting around biocompatibility, electrical safety, EMC, sterilization validation, packaging validation, and human factors engineering. Its clinical services include protocol design, IRB interactions, IDE submissions, subject recruitment, monitoring, data management, statistical analysis, and clinical reports.

Pricing and delivery

The website does not provide standard packages or a public price list. It only states that submission services may be delivered for a fixed fee and repeatedly directs users to “Request a quote.” This is more in line with project-based consulting procurement, making it suitable for companies that need clearly defined submission tasks and budget boundaries. Before purchasing, however, buyers should further confirm the service scope, milestones, deliverables, FDA communication responsibilities, and refund/change terms.

Pros and cons

Its strengths lie in a relatively complete service chain, covering regulatory strategy, product testing, quality systems, clinical trials, and manufacturing support. The site also emphasizes that its consultants have over 30 years of medical product experience, which may suit complex submission scenarios. The main limitation is the lack of SaaS characteristics: there is no visible online collaboration platform, account permissions, API, third-party system integrations, data security certifications, or customer portal description. Customer case studies, success rates, and detailed team credentials are also not sufficiently presented in the main content.

Who it is for and access from China

It is suitable for medical device and life sciences companies planning to enter the U.S. market and needing support with FDA 510(k) or related compliance pathways, especially small and midsize companies without an in-house regulatory team. For Chinese companies, the site does not state whether it offers Chinese-language service, cross-border payment options, contracting entity details, or information on website access from China, so china_access can only be assessed as unknown. If local communication and payment convenience are important, companies may also want to compare domestic regulatory consulting firms, CROs, or testing and certification providers with FDA submission experience.